Data / Form D filings / RELMADA THERAPEUTICS, INC.
RELMADA THERAPEUTICS, INC.: Form D filings
RELMADA THERAPEUTICS, INC., a biotechnology company in New York, NY, filed 10 Form D notices with the SEC between 2014 and 2019. The latest, on October 8, 2019, reports $825,750 sold of a $825,750 offering to 7 investors.
Find out what RELMADA THERAPEUTICS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 880 3RD AVENUE, 12TH FLOOR, New York, NY, 10022
- Phone
- (646) 876-3459
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1553643
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2019 | New notice | $825,750 | $825,750 | $0 | 7 | Sep 23, 2019 | sec.gov |
| Jul 10, 2019 | Amendment | $10,000,000 | $8,432,437 | $1,567,563 | 116 | Jun 14, 2019 | sec.gov |
| Jun 27, 2019 | New notice | $10,000,000 | $8,002,248 | $1,997,752 | 108 | Jun 14, 2019 | sec.gov |
| May 16, 2019 | New notice | $10,000,000 | $3,414,505 | $6,585,495 | 43 | May 14, 2019 | sec.gov |
| Dec 10, 2018 | Amendment | $10,000,000 | $5,834,407 | $4,165,593 | 66 | Oct 12, 2018 | sec.gov |
| Nov 13, 2018 | Amendment | $10,000,000 | $4,629,507 | $5,370,493 | 55 | Oct 12, 2018 | sec.gov |
| Oct 22, 2018 | New notice | $10,000,000 | $3,279,998 | $6,720,002 | 30 | Oct 12, 2018 | sec.gov |
| Oct 6, 2017 | New notice | $6,890,000 | $6,890,000 | $0 | 65 | Sep 28, 2017 | sec.gov |
| Jun 19, 2014 | New notice | $10,694,588 | $10,694,588 | $0 | 236 | Jun 10, 2014 | sec.gov |
| Jun 4, 2014 | New notice | $0 | $0 | $0 | 382 | May 20, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Maged Shenouda | Director | |
| Ottavio Vitolo | Executive Officer | |
| Paul Kelly | Director | |
| Charles Casamento | Director | |
| Chuck Ence | Executive Officer | |
| Sergio Traversa | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Oct 7, 2019 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RELMADA THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.